Integrating age, BMI, and serum N-glycans detected by MALDI mass spectrometry to classify suspicious mammogram findings as benign lesions or breast cancer

While mammograms are the standard tool for breast cancer screening, there remains challenges for mammography to effectively distinguish benign lesions from breast cancers, leading to many unnecessary biopsy procedures. A blood-based biomarker could provide a minimally invasive supplemental assay to...

Descripción completa

Detalles Bibliográficos
Autores principales: Blaschke, Calvin R. K., Hill, Elizabeth G., Mehta, Anand S., Angel, Peggi M., Laronga, Christine, Drake, Richard R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718781/
https://www.ncbi.nlm.nih.gov/pubmed/36460712
http://dx.doi.org/10.1038/s41598-022-25401-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718781/
https://www.ncbi.nlm.nih.gov/pubmed/36460712
http://dx.doi.org/10.1038/s41598-022-25401-0

Ejemplares similares